Prosecution Insights
Last updated: April 19, 2026

E-Therapeutics PLC

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19085810 INHIBITORS OF EXPRESSION AND/OR FUNCTION HUDSON, AMY ROSE 1636 Final Rejection Mar 20, 2025
18106158 CONJUGATED OLIGONUCLEOTIDE COMPOUNDS, METHODS OF MAKING AND USES THEREOF SHIN, DANA H 1635 Final Rejection Feb 06, 2023

Managing E-Therapeutics PLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month